Department of Urology and Paediatric Urology, University Medical Center Mainz, Mainz, Germany.
Center for Cardiology, University Medical Center Mainz, Mainz, Germany.
Urol Int. 2024;108(3):219-225. doi: 10.1159/000537808. Epub 2024 Feb 14.
The aim of the study was to investigate prevalence and impact of incidental renal masses (IRMs) accompanying increasing computed tomography (CT) work-up for symptomatic aortic valve stenosis (sAVS) of the elderly with regard to the relevance of urological consultation for overall survival (OS).
A retrospective analysis of pre-transcatheter aortic-valve implantations (TAVIs) CT scans of patients with sAVS (N = 1,253) harboring IRM was performed for 2014-2019. According to the clinical management, groups 1 (urologic consultation) and 2 (findings ignored) were formed and analyzed in terms of OS.
The prevalence of IRM was 9% (119/1,253). In 19% (23/119), urological advice was sought (group 1). At baseline, group 1 showed a significantly higher rate of malignancy-specific lesions compared to 2 (p < 0.01). Other clinical parameters (e.g., age, cardiological scores, comorbidities) did not differ between groups (p > 0.05). In group 1, 4 (17%) findings were histologically confirmed, of which 3 (13%) underwent surgery. There was no significant difference in median OS at a median follow-up of 24.7 months between groups 1 and 2 with 35.7 (95% CI, 5.9; 65.4) and 47.4 months (95% CI, 33.0; 61.7), respectively (p = 0.4). In Cox regression analysis, chronic kidney disease but not urologic work-up or chronic obstructive pulmonary disease or heart failure emerged as an independent unfavorable predictor of OS (HR 2.44, 95% CI 1.37; 4.36, p = 0.003).
For the first time, a TAVI population with IRM was analyzed from the urologist's perspective. Urologic co-evaluation and work-up does not confer a significant benefit in terms of OS in this particular population.
本研究旨在调查在因症状性主动脉瓣狭窄(sAVS)而行 CT 检查时偶然发现的肾肿瘤(IRMs)的发生率和影响,以评估泌尿科会诊对整体生存率(OS)的相关性。
对 2014 年至 2019 年期间接受经导管主动脉瓣植入术(TAVI)治疗的 sAVS 患者的 CT 扫描进行回顾性分析,这些患者均存在 IRM。根据临床管理情况,将患者分为两组:1 组(泌尿科会诊)和 2 组(忽略发现),并对两组患者的 OS 进行分析。
IRM 的发生率为 9%(119/1,253)。在 19%(23/119)的患者中,寻求了泌尿科建议(组 1)。在基线时,组 1 的恶性肿瘤特异性病变发生率明显高于组 2(p < 0.01)。其他临床参数(如年龄、心脏评分、合并症)在两组之间无差异(p > 0.05)。在组 1 中,有 4 例(17%)的发现得到了组织学证实,其中 3 例(13%)接受了手术。在中位随访 24.7 个月时,组 1 和组 2 的中位 OS 无显著差异,分别为 35.7 个月(95% CI,5.9;65.4)和 47.4 个月(95% CI,33.0;61.7)(p = 0.4)。在 Cox 回归分析中,慢性肾脏病而不是泌尿科检查或慢性阻塞性肺疾病或心力衰竭,成为 OS 的独立不利预测因素(HR 2.44,95% CI 1.37;4.36,p = 0.003)。
本研究首次从泌尿科医生的角度分析了 TAVI 人群中存在 IRM 的情况。在该特定人群中,泌尿科的共同评估和检查并不能显著提高 OS。